Profile of transforming growth factor-beta 1 in patients with dengue haemorrhagic fever

International Journal of Experimental Pathology

Volumn 80, Issue 3, 1999, Pages 143-149

  Agarwal, R ^a,b   Elbishbishi, E A ^d   Chaturvedi, U C ^c   Nagar, R ^a   Mustafa, A S ^d  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^c KUWAIT UNIVERSITY   (Kuwait)

^d NONE

Author keywords

Cytokine; Dengue; Dengue haemorrhagic fever; Pathogenesis; TGF 1

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DENGUE; HUMAN; HUMAN CELL; INFANT; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DENGUE HEMORRHAGIC FEVER; GENE EXPRESSION; HUMANS; INFANT; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032769730     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2613.1999.00107.x     Document Type: Article

References (26)

1. Agarwal R., Chaturvedi U.C., Misra A., Kapoor S. & Nagar R. (1998a) CD4 positive T cells produce cytotoxic factor in cases of dengue haemorrhagic fever. Curr. Sci. 74, 237-239.
2. Agarwal R., Chaturvedi U.C., Misra A. et al. (1998b) Production of cytotoxic factor by peripheral blood mononuclear cells (PBMC) of the cases of dengue haemorrhagic fever. Clin. Exp. Immunol. 112, 340-344.
3. Bhamarapravati N. (1993) Pathology of dengue haemorrhagic fever. In: Monograph on Dengue/Dengue Haemorrhagic Fever, No. 22. Ed. P. Thongcharoen. New Delhi: WHO-SEARO, pp. 72-79.
4. Charan S., Palmer K., Chester P., Mire-Sluis A.R. & Edington N. (1997) Transforming growth factor-beta induced by live or ultraviolet-inactivated equid herpes virus type-1 mediates immunosuppression in the horse. Immunology. 90, 586-591.
5. Chaturvedi U.C., Tandon P., Mathur A. & Kumar A. (1978) Host defence mechanisms against dengue virus infection of mice. J. Gen Virol. 39, 293-302.
6. Chaturvedi U.C., Dhawan R. & Mukerjee R. (1997) Immunosuppression and cytotoxicity of dengue infection in the mouse model. In: 'Dengue and Dengue Haemorrhagic Fever. Ed. D.J. Gubler and G. Kuno. Wallingford: CAB International Press. 289-309.
7. Chaturvedi U.C., Raghupathy R., Pacsa A.S. et al. (1999a) Shift from a Th1-type response to Th2-type in dengue haemorrhagic fever. Curr. Sci. 76, 63-69.
8. Chaturvedi U.C., Agarwal R., Misra A., Mukerjee R., Kapoor S. & Nagar R. (1999b) Cytotoxic factor in dengue haemorrhagic fever. Med. Principles Pract. 8, 26-31.
9. Ding A., Nathan C.F., Graycar J., Derynck R., Stuehr D.J. & Srimal S. (1990) Macrophage deactivating factor and transforming growth factors-β1, β2, and β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J. Immunol. 145, 940-944.
10. Gentry M.K., Henchal E.A., McCown J.M., Brandt W.E. & Dalrympl J.M. (1982) Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies. Am. J. Trop. Med. Hyg. 31, 548-555.
11. Haagmans B.L., Van Den Teerds K.J., Van Den Eijnden-Van Raaij A.J.M., Horzinek M.C. & Schijns V.E. (1997) Transforming growth factor beta production during rat cytomegalovirus infection. J. Gen. Virol. 78, 205-213.
12. Halstead S.B. (1993) Pathophysiology and pathogenesis of dengue haemorrhagic fever. In: Monograph on Dengue/ Dengue Haemorrhagic Fever. Ed. P. Thongcharoen. New Delhi: WHO-SEARO. pp. 80-103.
13. Hamida N. & Mustafa A.S. (1998) Cytokine gene activation in response to a nonspecific mitogen and specific antigens by peripheral blood mononuclear cells of healthy humans. J. Kuwait Med. Ass. 33, 16-21.
14. Hayden F.G., Fritz R., Lobo M.C., Alvord W., Strober W. & Straus S.E. (1998) Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defence. J. Clin. Invest. 101, 643-649.
15. Hernandez-Pando R., Orozco H., Arriaga E.K., Sampieri A., Larriva-Sahd J. & Madrid V. (1997) Analysis of the local kinetics and localization of interleukin-1α, tumour necrosis factor-α and transforming growth factor-β, during the course of experimental pulmonary tuberculosis. Immunology 90, 607-617.
16. Hsuan J.J. (1989) Transforming growth factors β. Brit. Med. Bull. 45, 425-437.
17. Kurane I. & Ennis F.A. (1994) Cytokines in dengue virus infections: role of cytokines in the pathogenesis of dengue haemorrhagic fever. Semin. Virol. 5, 443-448.
18. Li J.M., Shen X., Hu P.P. & Wang X.F. (1998) Transforming growth factor beta stimulates the human immunodeficiency virus 1 enhancer and requires NF-kappaB activity. Mol. Cell Biol. 18, 110-121.
19. Morris M.M., Dyson H., Baker D., Harbige L.S., Fazakerley J.K. & Amor S. (1997) Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection. J. Neurol. 74, 185-197.
20. Nimmannitya S. (1993) Clinical manifestations of dengue/dengue haemorrhagic fever. In: Monograph on Dengue/Dengue Haemorrhagic Fever. No. 22. Ed. P. Thongcharoen. New Delhi: WHO-SEARO. pp. 48-54.
21. Raghupathy R., Chaturvedi U.C., Al-Sayer H. et al. (1998) Elevated levels of IL-8 in dengue haemorrhagic fever. J. Med. Virol. 56, 280-285.
22. Su H.C., Leite-Morris K.A., Braun L. & Biron C.A. (1991) A role for transforming growth factor-beta 1 in regulating natural killer cell and T lymphocyte proliferate responses during acute infection with lymphocytic choriomeningitis virus. J. Immunol. 147, 2717-2727.
23. Tanaka S., Takenaka K., Matsumata T., Mori R. & Sugimachi K. (1996) Hepatitis C virus replication is associated with expression of transforming growth factor -alpha and insulin-like growth factor-II in cirrhotic livers. Dig. Dis. Sci. 41, 208-215.
24. Tsai J.F., Jeng J.E., Chuang L.Y., Chang W.Y. & Tsai J.H. (1997) Urinary transforming growth factor-beta1 in hepatitis C virus-related chronic liver disease: correlation between high levels and severity of disease. Hepatology. 25, 1141-1146.
25. Uhi E.W., Castleman W.L., Sorkness R.L., Busse W.W., Lemanske R.F. Jr & McAllister P.K. (1996) Parainfluenza virus-induced persistence or airway inflammation, fibrosis, and dysfunction associated with TGF-beta 1 expression in brown Norway rats. Am. J. Respir. Crit. Care Med. 154, 1834-1842.
26. Yoo Y.D., Ueda H.P., Ark K., Flanders K.C., Lee Y.I., Jay G. & Kim S.J. (1996) Regulation of transforming growth factor-beta1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV Pathogenesis. J. Clin. Invest. 97, 388-395.